drugset / Trial / NCT00256100
Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this project is to assess the safety and effectiveness of fondaparinux, a new drug to prevent blood clotting in the continuous dialysis machine used in intensive care patients who have kidney failure.
Timeline
- Start
- 2004-06
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fondaparinux | Other / unclassified | 10 mg | — |